ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Portal Innovations Expands Venture Development Platform to Atlanta

-- National Expansion Strategy Will Fuel Venture Portfolio Growth --

Portal Innovations today announced the expansion of its premier life sciences-focused venture development engine to Atlanta, Georgia, where it will invest in and provide the critical resources that early-stage companies need to grow and scale.

Portal employs a highly differentiated “Crafted Capital” platform to provide seed financial funding, access to fully equipped wet lab space, and management expertise to propel its portfolio from company creation through asset-derisking and ultimately, long-term value creation. Portal is extending its existing partnership with Trammell Crow Company to design and develop approximately 35,000 RSF of state-of-the-art wet lab and office space in the first phase of the Science Square Labs development to house portfolio companies and other life sciences tenants.

Life Sciences venture capital funds have experienced historic levels of investment over the past two years driving demand for access to talent and specialized lab space for start-ups aiming to address unmet needs across healthcare. Additionally, academic institutions across the U.S. have recruited key entrepreneurial faculty developing breakthrough technologies and need access to adjacent lab facilities, capital, management know-how and talent in order to start and grow companies. Portal is expanding its platform in select cities nationally to address these critical needs.

Since its launch in 2020, Portal has successfully and rapidly deployed its platform in Chicago where it houses a growing portfolio of high-potential life sciences ventures. Expanding in Chicago and nationally provides Portal portfolio companies and partners access to resources and opportunities in multiple markets as they grow and scale.

Atlanta, like Chicago, possesses all of the academic and medical research institutions, resources, civic leadership and talent necessary to establish a world-class life sciences innovation hub, where companies can start up and scale.

“Portal’s role in emerging ecosystems like Chicago and Atlanta is to build a world class early-stage biotech portfolio while bringing together the entire ecosystem to allow these companies to scale locally,” said John Flavin, Chief Executive Officer and Founder of Portal Innovations.

“We are excited to build upon our partnership with Portal Innovations and bring to Atlanta Portal’s unique crafted capital approach, where the best life sciences startups will have an opportunity to thrive,” said Katherine Lynch, Senior Vice-President at Trammell Crow Company.

Prior to opening Portal’s fully equipped lab space in 2024, the Company is working collaboratively with key ecosystem stakeholders including, among others, Georgia Bio, Center for Global Health Innovation, GRA Ventures, Metro Atlanta Chamber, Global Center for Medical Innovation, and key resources of talent and innovation at several academic and other research institutions in Atlanta and the region.

“Georgia is home to world-class universities, leading global healthcare companies and an unsurpassed pool of diverse talent. A shortage of life sciences seed capital and quality infrastructure to tie it all together have been needed to make it a world-class life sciences cluster,” said Maria Thacker Goethe, Chief Executive Officer at Center for Global Health Innovation and President & Chief Executive Officer at Georgia Bio. “Portal Innovations brings best-in-class lab facilities and venture support platform, including seed capital that will fuel innovation and make a major positive impact in keeping Atlanta’s best and brightest entrepreneurs and scientists right here and attract talent from throughout the region.”

About Portal Innovations

Portal Innovations is a premier venture development engine that bridges scientific ideation in life sciences, medtech and bioinformatics through commercial proof of concept by delivering crafted capital including seed funding, specialized equipment and lab space and management expertise to high-potential early-stage companies. For more information visit www.portalinnovations.com

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.00
+2.08 (1.00%)
AAPL  264.18
-8.77 (-3.21%)
AMD  200.21
-3.47 (-1.70%)
BAC  49.83
-2.47 (-4.72%)
GOOG  311.43
+4.28 (1.39%)
META  648.18
-8.83 (-1.34%)
MSFT  392.74
-8.98 (-2.24%)
NVDA  177.10
-7.79 (-4.21%)
ORCL  145.40
-4.91 (-3.27%)
TSLA  402.51
-6.07 (-1.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.